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Abstract 
This thesis describes a microwell-based microfluidic platform for 
high-throughput screening of protein crystallization conditions. The microfluidic 
system consisted of one poly(dimethylsiloxane) (PDMS) microchannel patch and 
one microwell patch that were reversibly bound. The PDMS elastomer was 
pre-degassed and served as an internal vacuum pumping source. Reagents with 
different chemical compositions were infused into the microwells through the PDMS 
microchannels. By removing the PDMS microchannel, arrays of reagent droplets 
confined in the microwells were obtained. Microwells fabricated in PDMS, 
poly(methyl methacrylate) (PMMA) and glass were all compatible with the 
dispensing process. A large variety of reagents with different wettabilities and 
viscosities were successfully tested. 
To illustrate the application of the microfluidic system，a sparse-matrix screening 
of crystallization conditions of several water soluble proteins was conducted by 
mixing the droplets of protein solution and the droplets of various precipitants 
pre-fabricated in two separate microwell patches. An unknown protein was also 
successfully crystallized by using the screening method in microwells and its 
crystals were harvested from the reversibly bound microwells. X-ray diffraction of 
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Chapter 1. Introduction 
1.1 Protein crystallization 
Protein crystallization is the bottleneck in determining the tertiary protein 
structure by X-ray diffraction from sequence data.� The completion of the Human 
Genome Project potentially allows us to identify a host of genetic disorders and 
design therapies to treat them. However, it is usually not the genes themselves that 
are the targets but the proteins encoded by them.2-5 The function of these proteins is 
determined by their tertiary structures. Therefore, it is essential to get a detailed 
understanding of the protein structure in order to developing therapeutic treatments 
and to engineering proteins with improved properties.^ Many efforts have been spent 
on it and much progress has been made in the past few years.^ The most powerful 
tool to determine 3D protein structure is X-ray crystallography, which requires 
high-quality protein crystals. Thus, protein crystallization has gained a strategic and 
commercial relevance in the post-genomic era and there have been considerable 
advances in the automation of protein preparation/ and X-ray analysis,8 modeling 
and bioinformatics.9 
However, protein crystallization is still a rate-limiting step, which has to be 
overcome by empirical trials and error approaches with hundreds of conditions for 
each p ro te in . 10 The crystallization of proteins is influenced by a number of factors, 
which are not independent of each other and their interrelation may be complicated 
and difficult to distinguish (Table 1.1). Therefore, it is difficult to predict which 
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condition can cause the crystallization of a protein. The only way to find the right 
conditions is to perform a large number of trials to identify these factors individually. 
Table 1.1 Important factors affecting macromolecule crystallization.� 
Physical Chemical Biochemical 
Temperature/Temperature 





Inherent symmetric of the 
Time/Rate of growth Precipitant concentration 
macromolecule 
Macromolecule 
Equilibrium rate Biochemical modification 
concentration 
Genetic/Post-transitional 
Dielectric constant of medium Ionic strength 
Modification 
Viscosity of medium Additive/Specific ions Isoelectric point 
Pressure Metal ions Macromolecule stability 
Aggregation state of 
Gravity Detergent/Surfactant 
macromolecule 
Homogeneity of Storage time of 
Degree of supersaturation 
Macromolecule macromolecule 
Reducing/Oxidizing ^ 
Electric/Magnetic fields Source of macromolecule 
environment 
Volume of crystallization Present of amorphous 
P r oteo ly s is/Hy d r 0 ly s is 
sample drop substances/impurities 
Methodology/Approach of 
Cross-linker Microbes contamination 
crystallization 
In the past several years, there have been some achievements on improving the 
throughput of protein crystallization screening and lowering the sample consumption 
by automating and miniaturizing crystallization.^Thousands of trials are set up 
per day and the subsequent analysis of the crystallization drops is also progressing at 
high speed. However, these methods rely on expensive robotic liquid dispensing 
system and are not widely adopted by individual laboratory. More recently, the 
PDMS-based microfluidic system provides an alternative to perform protein 
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crystallization at nanoliter scale, with the advantages of lowering the cost, time and 
reagent c o n s u m p t i o n . However, these methods have some limitations such as 
complicated background on microfluidics，i4’ i5 the shortcomings of PDMS 
materials 19 and the complicated fabrication^® and operation of the systems.'^ 
Therefore, developing new crystallization platforms which can be affordable and 
user-friendly to individual laboratories is still highly desirable. 
1.1.1 The principle of protein crystallization 
Different from small molecule crystals, protein crystals are labile, fragile and 
sensitive to the external environment owing to their high solvent content, and the 
weak binding energies between protein molecules in crystals. The crystallization of 
proteins from solution is a reversible equilibrium phenomenon. It contains three 
stages: nucleation, growth and cessation of growth. A classical explanation of crystal 
nuclei formation and growth can be visualized by the two-dimensional solubility 
phase diagram (Figure 1.1). The solubility curve divides the concentration space 
into undersaturated and supersaturated regions. In the undersaturated region, below 
the solubility curve, the protein will not crystallize. Above the curve, the 
supersaturated region is subdivided into three regions according to different levels of 
saturation. In the precipitation region, excess protein exists as an amorphous 
precipitate, implying no crystals. In the nucleation region, there is a high probability 
that critical nuclei will form spontaneously in solution. The metastable region is 
ideal for the growth of crystals without the formation of new crystals. In this region, 
nuclei will not form, but if nuclei are present or seed crystals are introduced then 
3 
crystals may grow larger. 
> 11 Supersaturated Region 
j ^ g j H B 
Precipitant Concentration • 
Figure 1.1 The solubility phase diagram for protein crystallization from solution. 
1.1.2 Protein crystallization approaches 
There are several techniques for setting up crystallization experiments, including 
vapor diffusion, batch, microbatch, microdialysis, free interface diffusion and 
seeding. Among these methods, vapor diffusion and microbatch are the two most 
common methods which are widely adopted by individual laboratories. 
Vapor diffusion is the most widely employed method for protein crystallization. 
Nucleation occurs when the sample concentration increases as the droplet volume 
decreases by hydration-driven mechanisms. This is induced by the equilibration of 
water vapor between the sample droplet and the reservoir solution (Figure 1.2). The 
most common protocols of vapor diffusion are the hanging drop and sitting drop 
methods. A drop (typically, 1 to 40 joL) containing the protein sample and the 
crystallization reagent is placed in a sealed chamber, and there is an extra reservoir 
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of crystallization reagent. Thus, the initial reagent concentration is less than that in 
the reservoir. To reach equilibrium, water leaves the drop and enters the reservoir. 
During this equilibrium process, the sample is also concentrated, increasing the 
relative supersaturation of the sample in the drop. 
Vapor diffusion Microbatch 
Protein & \ — 
I T y f T p — ^ j ^ t i 
r ^ m 
I Reservoir 
Figure 1.2 The sitting-drop vapor diffusion (left) and microbatch (right) method for protein 
crystallization. 
Microbatch method^ ^  is another method for rapid protein crystallization using 
microliters of protein sample per-trial. This method involves direct mixing of the 
unsaturated protein solution with precipitating solution, which alters the protein 
solubility and changes the dielectric properties of the medium to create a 
supersaturated environment to generate the crystal. In this method, a small drop of 
the sample (typically, 1 to 2 combined with the crystallization reagent is pipetted 
under a layer of paraffin oil, which allows little or no evaporation in the drop 
(Figure 1.2). A modified microbatch can be performed when the drop is p l a c e d 
under a mixture of paraffin oil and silicone oil, or straight silicone oil. ’ Such oils 
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allow water vapor to permeate from the drop and concentrate the sample. 
1.1.3 Screening strategies and approaches 
The post-genome era has now entered a phase of producing thousands of new 
proteins per year for structure analysis. Thus, developing strategies for screening of 
conditions of protein crystallization has become in demand. There have been several 
screening and optimization strategies, including randomized approaches such as 
sparse matrix screening,24 analytical approaches such as incomplete factorial,^^ 
90 
biological macromolecule database archives, “ automated grid searches and 
rational a p p r o a c h e s , e t c . These approaches are used to screen the initial 
crystallization conditions of proteins, which can subsequently be used to the 
optimization for producing large crystals. 
The sparse matrix screening is the most popular strategy and has been 
commercialized by Hampton Research (Crystal Screen 1 & 2)，Emerald BioSystems 
(Wizard I & II) and Molecular Dimension (Personal Structure Screen 1 & 2). 
Screening kits provided by these companies contain numerous conditions with 
different types of precipitating reagents, precipitant concentrations, buffers, pHs and 
salts. These conditions are empirically derived based on known or published 
crystallization conditions of various proteins?"^ With this strategy, high yields of 
crystals are obtained in the crystallization experiments. Furthermore, because the 
same conditions are used for initial screening of all protein samples, this approach 
shows the capability for automation. 
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1.2 Microfluidic systems for protein crystallization 
Since a large number of crystallization experiments are required to uncover the 
optimal conditions to crystallize a protein, the crystallization of the protein has 
become challenging, especially when dealing with limited amounts of protein 
sample. Therefore, developing new strategies with the ability to conduct the protein 
crystallization in nanoliter volume has attracted much attention and much progress 
has been achieved in microfluidic systems. 
Microfluidics is the science and technology of systems that process or 
manipulate small (10'^ to liters) amounts of fluids, using channel with 
dimensions of tens to hundreds of micrometers. Initially, microfluidics was 
dedicated to significantly reducing sample consumption and increasing the efficiency 
of separation.33-36 Within microfluidics, fluids (liquid or gas) are transported or 
stored in the microchannel or microchamber for reaction and detection. High 
resolution and sensitivity of detections and assays are performed with small 
footprints of the microfluidic devices and small amounts of reagents. As an emerging 
field, microfluidics is essentially multidisciplinary, including the microfabrication 
techniques20，and a wide range of applications, such as enzymatic assays,^^ kinetic 
studies of protein folding,^^ protein crystallization, 14’ ^^  the detection and analysis of 
DNA.40-43 Microfluidics not only obtained great successes in analysis, but also found 
many applications in other fields, such as fluid physics,44 microbiology'^^ and 
chemical synthesis,46 etc. 
Microfluidics, due to its small dimension of the reaction volume and the unique 
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mass transport properties,斗斗’ 47 which allows the control of molecules in space and 
time, has become a viable technology for the studies of protein crystallization.''^"'^' 
48’ 49 These microfluidic systems are focusing on two separate strategies: (i) 
microchambers with large-scale integration of active microvalves^"^ and (ii) droplets 
in an immiscible carrier fluid. ^ ^ 
__賺 
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Figure 1.3 The PDMS membrane valve. The image (left) shows the overlap of a control channel and a 
fluid channel. The image (right) shows the membrane fully deflected into the fluid channel, effecting 
a tight seal. (Image from http://www.fluidigm.com/) 
1.2.1 Integrated valve-controlled microfluidic system 
In this system, the protein solution and precipitants are loaded into 
microchambers through a large array of valve-controlled identical fluidic units.！々 
These pneumatic valves are fabricated of PDMS elastomer using multiplayer soft 
lithography (MSL) method.^® The basic microfluidic device was composed of two 
elastomer layers (Figure 1.3). One layer contains channels for flowing liquids (flow 
layer), and the other layer contains channels that when pressurized with air or 
nitrogen serve as valves for the flow channels (control layer). When a control 
channel and a flow channel cross, if the area of the intersection is large enough, a 
valve is created. The thin membrane separating the two channels deflects into the 
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flow channel when the control channel is pressurized, creating a complete seal. The 
protein crystallization microchip has 432 active valves and can simultaneously 
perform 144 crystallization experiments using only 3 )jL of protein sample. 
Conditions of protein crystallization are screened and optimized by free interface 
diffusion. However, this system has several drawbacks. The 3D fabrication of the 
pneumatic valves is complicated.^^ In addition, the microchip is made of PDMS 
elastomer, which is permeable to many solvents,'^' ^^  suffering from the lack of 
long-term storage capability. 
1.2.2 Droplet-based microfluidic system 
Different from the above valve-controlled system, the droplet-based microfluidic 
system allows performing the screening of conditions of protein crystallization in 
nanoliter size droplets which are generated in the microchannel.'^ In this method, 
continuous aqueous streams containing the protein and the precipitants are combined 
and injected into a carrier fluid, forming aqueous plugs/droplets containing the 
protein and the precipitants. Thousands of droplets are formed in the microchannel, 
which could flow out and into a glass or Teflon capillary]6’ i7 This method has well 
addressed the issues such as the storage of the crystallizing reagents in glass 
capillary 16 or Teflon capillary,and the indexing of the concentration in the plugs.^^ 
Both the microbatch and the vapor diffusion approaches have been successfully 
preformed in the droplet-based microfluidic system.^^ However, there are still 
several issues: the size and frequency of the droplets/plugs formation, and the 
spacing of droplets in a continuous flow depend much on the fluid physics, suffering 
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from liquids with different wettabilities and viscosities.^^ In addition, the user 
interface is not friendly to researchers without background on microfluidics by using 
syringe pumps, which have to be controlled by computer programs. These issues 
hinder the adoption of this technique by individual laboratories. 
1.2.3 Objective of the research 
Although there are several drawbacks and issues on the previous microfluidic 
systems, they have demonstrated the capabilities of performing protein 
crystallization at nanoliter scale. In order to make the microfluidic technology 
become more practical, affordable and comfortable to the users without strong 
background on microfluidics, new strategies and efforts are in demand.^^ 
麗 
Figure 1.4 A schematic illustration of the microwell-based microfluidic platform for screening of 
conditions of protein crystallization. 
Herein, to address the issues and lower the barrier of use, we developed a 
microwell-based microfluidic platform to conduct the screening of protein 
crystallization conditions at nanoliter scale (Figure 1.4). In this method, chemically 
distinct reagents were infused into arrays of microwells through the reversibly sealed 
PDMS microchannels, which were pre-degassed and served as an internal vacuum 
1 0 
pumping source. By removing the PDMS microchannel patch, arrays of droplets 
confined in the microwells were obtained. Multiplex reaction and screening at 
nanoliter scale were carried out by binding two such arrays of microwells. We 
demonstrated the applications of this microfluidic platform by performing the 
screening of conditions of protein crystallization. 
I present the detailed illustration of the nanoliter liquid dispensing method in 
chapter 2. The application of this microfluidic system in the screening of conditions 
of protein crystallization is described in chapter 3. Finally, I present my conclusions 
and future directions in chapter 4. 
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Chapter 2. Nanoliter Liquid Dispensing 
Method 
2.1 Introduction 
Liquid dispensers at nanoliter scale offer the possibility of high throughput of 
chemistry and biology, allowing numerous experiments performed rapidly in parallel, 
while consuming little amount of reagents. Many sophisticated methodologies of 
liquid dispensing have been developed and some have been incorporated in robotic 
systems.53 For example, dispensers using micropistons or microsolenoid components 
have been commercialized and can pipette as little as 50 nL liquid. Piezoelectric 
dispensing has been adopted for better accuracy and consistency, especially in inkjet 
printing systems.54-56 in pintool systems, tiny metal needles are dipped into the target 
, liquid, and 2 nL to 500 nL liquid can be delivered by capillary and surface tension 
forces.57 Acoustic dispensing^^' ^^  has also been used to inject droplets of liquid from 
a reservoir.6o All these methods have achieved some success with notable limitations. 
For example, many of these methods suffer from inconsistent results from liquids of 
different viscosities or surface tensions, and nozzle obstructions or clogs might occur 
even in the mature dispensing technologies.^^ In addition, these methods require 
sophisticated electronic and mechanical controlling system and are costly in both 
manufacturing and maintenance. 
In contrast with the above-mentioned methods and commercial equipments, 
PDMS based microfluidic system offers a low-cost and simple platform for liquid 
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dispensing at nanoliter scale. Yamada et al. exploited the hydrophobicity of PDMS to 
control the movement of aqueous solutions.^^ Nanoliter solution was infused into 
PDMS microchambers with accurate control of the volume. However, this method 
was limited to aqueous solutions and required precise control of pressure on the 
solution. On the other hand, the high solubility and permeability of air in PDMS was 
also exploited in PDMS microfluidic channels to generate flow,63，64 and to dispense 
nanoliter liquid into microwells or microchambers.‘斗’ 65 NUZZO and co-workers 
developed a channel outgas t e c h n i q u e , � in which the inlet of the microfluidic 
device was immersed in the target solution while the whole system was in vacuum. 
As the device was brought back to atmosphere, the target solution was infused into 
the PDMS device due to the reduced pressure in the microchannel. This method 
consumed at least 20 \xL of sample, and was incompatible with solutions containing 
volatile solvents.^^ Hosokawa et al. improved this method by degassing the PDMS 
device in vacuum and then adding the target solution to the inlet in atmosphere.^^ 
Hansen et al proposed a method of infusing liquid into nanoliter PDMS chambers 
by driving the air in the chamber out to atmosphere through PDMS with high 
external pressure on the l iquid . i4 The drawback of this method was the complex 
fabrication and operation of the PDMS device. These liquid dispensing methods 
using the permeability of air in PDMS were effective for disposable devices for 
short-term (hours) analysis, however, long-term (days to weeks) storage, incubation 
or reactions would be difficult due to the permeability of water and many other 
solvents in PDMS.64 
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Herein, I describe an alternative approach to dispensing nanoliter liquid using 
PDMS microfluidic system. The dispensing setup consisted of a PDMS 
microchannel patch and a microwell patch (Figure 2.1). The PDMS microchannel 
patch was pre-degassed and served as an internal vacuum pumping source. With this 
method, various reagents were dispensed into arrays of microwells through the 
reversibly sealed degassed PDMS channel patches. By removing the channel patches, 
reagents in the open microwell array were obtained. This method had been 
successfully tested with substrates such as PMMA and glass, and liquids with 
different wettabilities and viscosities. 




(PDMS, PMMA, glass) 
Figure 2.1 The schematic illustration of the assemble microfluidic device. 
2.2 Experimental 
2.2.1 The fabrication of SU-8 master 
SU-8 master was fabricated using photolithography method.^^ Silicon water (3 
inches) was cleaned by immersion in a solution of H2SO4/H2O2 (v/v 3:1) for 10 
minutes. The wafer was rinsed thoroughly with deionized water and dried with 
compressed air. Then the wafer was further dehydrated in an oven at 110 for 1 
14 
hour. 
Table 2.1 Recommended conditions for the SU-8 photoresists. 
Photo Thickness Spin speed Soft bake (min) PEB (min) 
resists (^m) (rpm) ti(65�C) t2(95�C) t3(65�C) U 9 5 � C ) 
。 100 3000 5 20 1 10 
SU-8 2100 
,, , 140 2000 5 35 1 15 
(Microchem) 
260 ^ 7 ^ 1 15 
… ， … 10 2 5 5 5 5 30 5 20 
GM 1060 
… , 25 1335 10 35 10 30 
{Gersteltec) 
50 565 10 60 10 30 
Two types of SU-8 photoresist, SU-8 2100 (MicroChem) and GM 1060 
(Gersteltec Sari.), were used to fabricate masters for the microwell and microchannel, 
respectively. We followed the recommendation parameters of the SU-8 photoresists 
to fabricate features with different heights (Table 2.1). The SU-8 photoresist was 
poured carefully onto the center of the clean silicon wafer and then coated on the 
silicon wafer using a spin-coater (KW-4A, IMECAS). The wafer was placed on the 
75 °C hotplate (the surface temperature was 65 by thermometer) and baked for ti 
minutes and further baked at 105 (the surface temperature was 95 °C by 
thermometer) for t2 minutes. Then the wafer was removed and allowed to cool down 
before UV exposure. A transparency mask was used to pattern the SU-8 photoresist 
by UV exposure. The experimental setup about the UV exposure step was illustrated 
in Figure 2.2. After the exposure, the wafer was baked at 75 hotplate for ts 
minutes and at 105 °C hotplate for t4 minutes. The wafer was then developed in a 
bath of SU-8 developer (MicroChem), in which the unexposed photoresist was 
removed, and then rinsed with isopropanol. Finally, the resulting wafer was dried by 
N2 flow and stored in the oven at 60 °C before use. Thus, SU-8 masters with 
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different features were fabricated. 
1. stage 
2. silicon wafer 
3. photoresist U V 
4. photomask 
5. quartz silde 
6. SU-8 filter J ” 
Figure 2.2 A schematic illustration of the UV exposure experimental setup. 
SU-8 master was treated with "air plasma" (SPI Plasma-Prep II) for 2 minutes 
and placed in a vacuum desiccator along with several drops of the silanizing agent 
(tridecafluoro-l, 1, 2, 2-tetrahydrooctyl trichlorosilane) for 2 hours. 
2.2.2 The fabrication of PDMS microfluidic device 
(i) Spin SU-8 on silicon wafer (ii) u v exposure I ^ ^ • 
( U - 8 p h o t o r e s ^ ^ ^ ^ ^ ^ ^ 
Photomask ^ ^ ^ ^ ^ 
\ ? D M S (ill) Bake 
/ \ ^ m i c r o w e l l & develop 
/ PDMS photoresist 
(V) Peel off the PDMS patch (丨Pour liquid PDMS 
& cure at 60 C 
Figure 2.3 The procedures of the rapid prototyping method to fabricating PDMS microwells 
PDMS microchannel and microwell patches were fabricated using replica 
molding method (Figure 2.3).^ ^ 
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MicroChannel and microwell patches with the thickness of 3 mm were then 
fabricated by casting a 10:1 (in weight) mixture of PDMS precursor and curing agent 
(Sylgard 184, Dow Corning) against the SU-8 master and curing the mixture at 60 
for over 2 hours. Finally, the PDMS patches were peeled away from the SU-8 
masters. 
2.2.3 The fabrication of glass and PMMA microwells 
For microwell patches made in glass, glass microscope slides patterned by SU-8 
photoresist with the thickness of 100 |im were first fabricated by photolithography. 
Only the microwell area was exposed. The glass slide was then soaked in 10% HF 
aqueous solution for 75 minutes, followed by rinsing with deionized water and 
drying with N2 flow. The SU-8 photoresist on the microscope slide was removed by 
soaking the slide in a solution of H2SO4 and H2O2 (v/v 3:1) for 10 minutes and then 
rinsing with deionized water. The depth of the glass microwell was measured by a 
profilometer (Tencor Alpha-step 500 Surface Profiler) as 110 |am. 
Poly(methyl methacrylate) (PMMA) microwells were fabricated by drilling 
PMMA slides using drill press with a cobalt micro-drill bit with the diameter of 0.30 
mm. 
2.2.4 The liquid dispensing into microwells 
(a) Assembly of the microfluidic device 
A PDMS microchannel patch was reversibly bound with a microwell patch made 
in PDMS, PMMA or glass, forming a microchip (Figure 2.4). Two types of 
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channel-microwell configurations were used in our experiments to introduce liquids 
into microwells via serial filling and parallel filling. Typically, the dimension of the 
microchannel was 50 |am in width, and 10 i^m in depth. PDMS microwells were 150 
f^ m in depth and glass microwells were 110 |_im in depth. 
(a) Serial filling (b) Parallel filling 
dead-end __ 
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Figure 2.4 A schematic illustration of the two strategies of liquid dispensing through the degassed 
PDMS channel patch: a) serial filling using a straight microchannel; b) parallel filling using a 
branched microchannel. Both of the two strategies have the same three major steps described in the 
middle column of the figure. 
(b) Liquid pre-loading 
To prepare Teflon tubing pre-filled with the reagent, a piece of Teflon tubing was 
attached to a 50 i^L syringe. The tubing was then inserted into the reagent. By 
pulling back the plunger of the syringe, the reagent was aspirated into the tubing at 
the scale of microliters. Finally the segment of the Teflon tubing containing the 
reagent was cut off and used for the dispensing. In the control experiment, liquid was 
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directly pipetted at the inlet of the microchannel. 
(c) Liquid dispensing 
Two strategies of the liquid dispensing were present by varying the configuration 
of the microchannel to achieve serial filling and parallel filling of microwells 
(Figure 2.4). 
Serial filling. The microchip was placed in a vacuum desiccator for 10 minutes 
of degassing at 6 kPa. After the microchip was brought back to atmosphere, a 
segment of Teflon tubing pre-filled with the reagent was inserted into the inlet of the 
microchannel to start the dispensing. After the completion of the dispensing process, 
the microchip was covered with a layer of silicone oil (Fluid 5, Brookfield). The 
PDMS microchannel patch was then removed from the microwell patch. 
Parallel filling. The microchip was placed in a vacuum desiccator for 10 minutes 
of degassing at 6 kPa. After the microchip was brought back to atmosphere, a 
segment of Teflon tubing pre-filled with the reagent was inserted into the inlet of the 
microchannel to start the dispensing. After the completion of the dispensing process, 
the dead-end of the microchannel was cut off with a sculpture blade. Subsequently, a 
second liquid, typically, silicone oil or paraffin oil that is immiscible with the 
aqueous solution was dispensed at the open dead-end. Then the oil was infused into 
the main channel by pulling backwards the syringe which was previously connected 
with the inlet of the channel, isolating the reagents in the microwells. Finally the 
channel patch was peeled off, resulting in arrays of reagents in the microwells. To 
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prevent the evaporation during the storage, paraffin oil was introduced to cover the 
microwells. 
Both the serial filling and parallel filling strategies were used in the experiments. 
Occasionally some air bubbles formed in the microfluidic channel during the 
dispensing process, but they disappeared very fast due to the dissolving of air into 
the PDMS parts, and no clogging was observed during the whole dispensing process. 
By a combination of serial filling and parallel filling, we managed to increase the 
throughput of liquid dispensing. 
2.3 Results and discussions 
2.3.1 The internal vacuum pumping source 
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Figure 2.5 A schematic illustration of the method of dispensing liquid into an array of microwells 
through the degassed PDMS microchannel. a) The degassing of the PDMS patch in a vacuum 
chamber, b) The re-dissolving of air into PDMS from atmosphere, c) The aspiration of the liquid into 
the microchannel and the microwells after a segment of tubing pre-loaded with the liquid was inserted 
into the inlet, d) The completion of the dispensing process when the liquid filled up the whole 
vacancy. 
Mechanism: As shown in Figure 2.5，while the PDMS microchannel patch was 
placed in a vacuum chamber, the air dissolved in the PDMS was gradually depleted. 
Once the PDMS patch was taken out and exposed to atmosphere, air slowly diffused 
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back into the PDMS.^^'^^ The diffusion occurred both on the surface and through the 
PDMS microchannel. When the reagent was placed at the inlet to block the air flow 
into the PDMS microchannel, the internal pressure in the microchannel decreased 
due to the continuous dissolving of air inside the microchannel into PDMS. As a 
result, a pressure difference was generated between the internal and external of the 
microchip. The reagent was aspirated into the microchannel and gradually filled up 
the whole vacancy of the closed system, without the formation of air bubbles. 
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Figure 2.6 (a) A micrograph of four arrays of circular-shaped microwells filled with aqueous 
solutions of Fe(SCN)x3-x (red), Cu(NH3)6^^ (blue), NaCl (colorless) and KMnOg (purple), respectively, 
(b) A micrograph of Fe(SCN)x^"'' aqueous solution in rectangular-shaped microwells with decreasing 
volume, (c) A micrograph of Fe(SCN)x^"'' aqueous solution In glass microwells. (d) A micrograph of 
Fe(SCN)x3-x aqueous solution in PMMA microwells. Scale bar: 2 mm. 
The dispensing method using degassed PDMS was compatible with microwells 
of different geometries, sizes and substrate materials (Figure 2.6). Reagents of 
different chemical compositions were successfully filled into arrays of microwells by 
using isolated parallel microchannels (Figure 2.6a). The small dimension of the 
microchannel (50 |im in width and 10 |im in height) facilitated the alignment on top 
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of the microwells of different volumes and geometries (Figure 2.6b). The elasticity 
of PDMS and the negative pressure in the microchannels allowed the PDMS 
microchannel patch to make conformal contact with many different substrates, and 
to form leak-free reversible sealing. As a result, microwells fabricated in glass and 
PMMA were filled smoothly using degassed PDMS microchannels (Figure 2.6c and 
d). 
Instead of simply adding a droplet of liquid at the inlet of PDMS microchannels, 
the liquid was loaded into the inlet by inserting a segment of Teflon tubing that was 
pre-loaded with the liquid (Figure 2.7). Due to the extremely small opening (< 260 
^im) of the Teflon tubing, the evaporation of the liquid in the tubing was significantly 
slowed down. The Teflon tubing also protected the reagent against contamination 
from the surface of the patch and from the liquids at other inlets. The consumption of 
the liquid could be precisely controlled by using Teflon tubing, eliminating the dead 
volume and minimizing the waste of the liquid during the dispensing process. 
圖 
Figure 2.7 A photograph of a PDMS microchannel patch on top of a patch of a 3 x 5 2 array of 
microwells, with 52 segments of Teflon tubing pre-loaded with the aqueous solution inserted into the 
inlets of the microchannels. The microwells were filled with Fe(SCN)x^"'叫ueous solution via the 
degassed PDMS microchannels. 
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2.3.2 The efficiency of the pumping 
The time needed for filling an array of microwells ( / to ta l ) is an important 
parameter for assessing the efficiency of the liquid dispensing. We studied the 
dependence of t^otai on four factors: (1) the duration of the degassing process in the 
vacuum chamber (广degas)，(2) the duration when the PDMS microchannel was 
exposed to atmosphere before the inlet was blocked by the liquid (^ exposure), (3) the 
total number of the microwells to be filled through one microchannel («)，and (4) the 
properties of the liquid, i.e., the viscosity and wettability. In all the experiments, the 
thickness of the PDMS patches was 3 mm and the dimension of microchannel was 
50 ]im (width) x 10 jam (height). The microwells were 400 [im in diameter and 150 
jim in height, and were fabricated in PDMS. For the first three characterization 
experiments, water was used as the testing liquid. 
Figure 2.8a shows the t^otai at different d^egas for 9 microwells connected by one 
PDMS microchannel, while the e^xposure was constant at 1 minute. The /'total decreased 
rapidly from 9 to 2 minutes as the d^egas increased from 1 to 10 minutes. Then the 
d e c r e a s i n g rate of the t^otai slowed down significantly, when ,totai decreased from 2 to 
1 minute as the degassing time increased from 10 to 60 minutes. This result indicated 
the degassing of PDMS patch was reasonably rapid and the air in the PDMS was 
mostly depleted within the first 10 minutes of the degassing. Therefore, the d^egas was 
set at 10 minutes for the rest experiments. 
We then measured the t^otai at different /exposure for 9 microwells connected by one 
PDMS microchannel (Figure 2.8b). As the e^xposure increased, the vacuum level of the 
23 
PDMS patch decreased, so did the aspiration force for d i s p e n s i n g the liquid. The /total 
increased almost linearly from 2 to 11 minutes with the /'exposure in the range of 1 to 30 
minutes. In our experiments, it usually took a few seconds to manually insert one 
segment of Teflon tubing to start the dispensing, and about 10 minutes to insert fifty 
segments of Teflon tubing sequentially to dispense fifty different liquids. The very 
slow decay of the aspiration force of the PDMS patch provided enough time for 
dispensing such a large number of different liquids. For dispensing liquids of many 
more than fifty types, a simple automated system that can handle multiple segments 
of tubing in parallel would be beneficial. 
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Figure 2.8 (a) Plot of /total versus ^degas- (b) Plot of Aotal versus /exposure- ( c ) Plot o f / t o t a l (•) and /average ( • ) 
versus the number of microwells to be filled via a single PDMS microchannel («). (d) Plot of 广total of 
different liquids. The error bars were from 5 independent measurements. 
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We measured the rtotai versus different total number of microwells (n) to be filled 
through a single PDMS microchannel, while e^xposure was constant at 1 minute 
(Figure 2.8c). The average time for filling each microwell (/'average) was then 
calculated a s ^average = ,totai / We found that (average remained constant at about 12 
seconds with n ranging from 9 to 36. For larger values of « (« > 36)，the (average 
increased almost linearly with n. Therefore, to achieve short average filling time and 
increase the throughput, parallel microchannels should be employed to fill a large 
number of microwells. 
We also studied the t^otai of 9 microwells with liquids of different wettabilities and 
viscosities (Figure 2.8d). e^xposure was constant at 1 minute. The driving force of the 
dispensing included the negative pressure in the PDMS microchannel and the 
capillary force. By comparing the values of rtotai between the liquids with opposite 
directions of capillary force and similar viscosity, such as water and ethanol, we 
concluded that the negative pressure dominated in driving the liquid into the 
microchannels. Liquids with various viscosities and wettabilities were dispensed 
reliably through the degassed PDMS microchannels. Among the liquids that we 
tested, the most difficult type was aqueous solution with high viscosity, e.g., 80% 
(w/w) glycerol aqueous solution with a viscosity of 44.6 mPa s at 23°C, and the 
negative pressure was strong enough to aspirate the glycerol solution into 9 
microwells in - 11 minutes. 
All the microwells were successfully filled by the target liquid, no air bubbles 
were formed after the dispensing process. 
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2.3.3 The removal of PDMS channel patch 
In the present dispensing method, the PDMS microchannel patch was reversibly 
bound to the microwell patch. Such reversible sealing of the PDMS microchannel 
had a number of applications such as surface pat terning,7� -72 microfabrication^^ and 
cell a n a l y s i s . 7 4 ， ” In the present study, the PDMS microchannel patch was removed 
after the dispensing process to generate arrays of liquid droplets in the open 
microwells. However, directly peeling off the PDMS microchannel patch in air 
caused two problems: (1) the evaporation of the liquid in nanoliter volume was rapid; 
(2) the liquid in some microwells spilled over the surface of the microwell patch. 
To solve these problems, we placed the reversibly bound patches in a silicone oil 
bath before removing the PDMS microchannel patch (Figure 2.9a). The evaporation 
of the liquid was effectively prevented by the oil layer on top. As the PDMS 
microchannel patch was lifted from the microwell patch, silicone oil filled the gap 
and the PDMS microchannels. As a result, the liquid in the PDMS microchannels 
merged into the droplet in the nearest microwell, while all the droplets remained 
confined in the microwells. By removing the PDMS microchannels presented in 
Figure 2.6, arrays of droplets with d i f f e r e n t reagents or with different volumes in 
PDMS microwells, and droplets in glass microwells or in PMMA microwells were 
obtained (Figure 2.9b � e ) . 
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Figure 2.9 a) A schematic illustration of the process of removing the microchannel patch in the 
presence of silicone oil. b) PDMS microwells filled with Fe(SCN)x^-'' (red), Cu(NH3)6^'' (blue), NaCl 
(colorless) and KMn04 (purple) aqueous solutions, respectively, c) PDMS microwells with a volume 
ratio of 1:2:4 filled with Fe(SCN)x^-'' aqueous solutions, (d) Glass microwells filled with Fe(SCN)x^"'' 
aqueous solutions, (e) PMMA microwells filled with Fe(SCN)x^"'' aqueous solution. Scale bar: 2 mm. 
The volume of the liquid dispensed into each microwell was determined by the 
volume of the microwell. The PDMS microchannels were 10 in height, 50 jam in 
width and 2 mm long between two neighbor microwells, while the typical 
microwells were 400 [im in diameter and 150 |am in height. The volume ratio of the 
microchannel to the microwell was 1:20, thus the volume contribution of the liquid 
from the microchannel to the droplets in the microwell was negligible. 
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Figure 2.10 The liquid dispensing method using branched microchannels. a) The simultaneously 
filling of an Fe(SCN)3 aqueous solution into the microwell array, b) The completion of the filling 
process, c) The introduction of the second liquid (silicone oil) into the main channel to isolate the 
microwells. d) Microwell arrays after peeling off the channel patch. 
An alternative way of controlling the volume more precisely is using a branched 
microchannel to fill the microwells in parallel. Figure 2.10 illustrates the whole 
process of liquid dispensing using branched microchannels. In this process, liquid 
was filled simultaneously into the microwell array through the branches on the main 
channel (Figure 2.10a) and no air bubble or clogging was observed during the filling 
(Figure 2.10b). After the completion of the filling, the other end of the channel was 
open by cutting off using a sculpture blade and then a second liquid (typically, 
silicone oil or paraffin oil) was introduced into the microchannel. The liquids in the 
microwell array were isolated by the second liquid in the main channel (Figure 
2.10c). Afterwards, the channel patch was peeled off, resulting arrays of reagent 
droplets in the microwells (Figure 2.10d). As the length of the branch channel can 
be well determined, volume of reagents thus can be more precisely controlled. 
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2.4 Conclusion 
In this chapter, a nanoliter liquid dispensing method is presented to deliver 
various reagents into array of microwells through the degassed PDMS channel patch. 
By exploiting the high gas permeability of PDMS elastomer, a significant aspiration 
power was generated and stored inside the degassed PDMS patch. When the inlet of 
the dead-end PDMS channel was blocked by the target liquid, due to the continuous 
dissolving of air from the sealed chamber into the degassed PDMS parts, a pressure 
difference was generated and served as a pumping source to start a flow until all the 
empty space was filled up by the liquid. Due to the nature of reversible sealing 
between the PDMS channel patch and the microwell patch, arrays of reagent droplets 
in the open microwells were fabricated by removing the channel patch, allowing 
further assaying and screening. Moreover, the amounts of the reagents were 
precisely controlled by employing extremely small filling microchannel. In addition, 
the use of oil could significant slow down the evaporation of nanoliter droplets in the 
microwells. PMMA and glass microwells, and various liquids with different 
wettabilities and viscosities, were successfully tested by this method. 
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Chapter 3. The Screening of Protein 
Crystallization Conditions 
3.1 Introduction 
As mentioned in chapter 1，protein crystallization is a bottleneck in determining 
tertiary protein structures from the sequence data] The conditions of protein 
crystallization are usually identified by screening a large number of precipitants 
under the condition of microbatch or vapor diffusion.^^ 
Conventional protein crystallization screening is typically performed by pipetting 
protein and crystallization reagents together by hand, in which case solutions can be 
accurately dispensed on the order of 1 jjL, or they can be pipetted robotically, in 
which case solutions can be accurately dispensed on the order of 10 � 1 0 0 nL. 
Hand-pipetting is a labor consuming process, while the robotic dispensing systems 
are expensive and not widely adopted by individual laboratory. 
Recently much progress has been achieved in developing microfluidic techniques 
for protein crystallization with the advantages of little sample consumption and high 
throughput. 14’ 15’ 17’ 18，31 However, there are still a few issues of protein crystallization 
in microfluidic devices that impede their adoption in laboratories, including the 
complex device fabrication and operation,14’ ^^  and the requirement of sophisticated 
instrument for flow control/"^' 、， 
As described in chapter 2, a simple microwell-based platform with the 
capability of screening conditions of protein crystallization was developed by using 
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two arrays of reagents in the open microwells. To demonstrate the application of this 
microwell-based microfluidic platform, we conducted a sparse matrix screening of 
protein crystallization conditions. We carried out the screening under the microbatch 
condition by mixing the droplets of protein solution and the droplets of various 
precipitants pre-fabricated in two separate microwell patches (Figure 3.1). Crystals 
grown in the microwells could be harvested and mounted for X-ray diffraction from 
the open microwells after the two patches were peeled apart. 
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Figure 3.1 A schematic illustration of the screening of conditions of protein crystallization by mixing 
protein solution and precipitants from two microwell patches. 
3.2 Experimental 
3.2.1 The design and fabrication of the screening chip 
156-microwell patches were fabricated for screening conditions of protein 
crystallization using the designs shown in Figure 3.2. The purpose of these designs 
was to increase the throughput of the screening up to 156 trials on one microchip. 
The PDMS microchannel and microwell patches were fabricated using rapid 
prototyping method.^^ Typically, the depth of the microchannel and the microwells 
3 1 
were 10 |im and 150 |am, respectively. 
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Figure 3.2 The layouts of the designs of the channels and microwells for 156-trail screening of 
conditions of protein crystallization, a) The channel for the filling of protein solution, b) The channels 
for the filling of crystallization reagents, c) 156-microwell array for loading the protein solution and 
the crystallization reagents. Scale bars: 1 mm. 
3.2.2 The screening of protein crystallization conditions 
The 156 microwells were divided into 52 groups of 3 microwells. The 
microwells in each group were filled with the same precipitant solution. Four 
proteins were used for the screening test: chicken egg-white lysozyme (Wako, Japan) 
(60 mg/ml in 50 mM sodium acetate buffer, pH 4.5), thaumatin (Wako, Japan) (50 
mg/ml in 0.1 M N-(2-acetamido)iminodiacetic acid buffer, pH 6.5)，xylanase 
(Sigma-Aldrich) (10 mg/ml in 43% (w/v) glycerol / 180 mM phosphate buffer, pH 
7.0) and horseradish peroxidase (Sigma-Aldrich) (5 mg/ml in 0.1 M phosphate buffer, 
pH 7.2). The 50 precipitant reagents were from a commercial screening kit (Crystal 
Screen, Hampton Research). Microwell patches containing protein solution and 
precipitant reagents were pre-fabricated separately by using the dispensing method 
described in chapter 2 and were covered with silicone oil. The two microwell 
patches were aligned under the microscope and bound together for mixing. The 
resulting microchip was incubated in paraffin oil (BDH, England) bath. The crystals 
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of the proteins were examined by using a polarized light microscope (Leica MZ 16, 
Germany) equipped with a CCD camera (SPOT Insight, Diagnostic Instruments). 
3.2.3 Crystallization and X-ray diffraction of an unknown protein 
An unknown protein, HP0753, was obtained by expressing the gene in E. coli 
followed by affinity purification. The final concentration of the protein was 6 mg/ml 
in 50 mM Tris buffer, pH 7.5 / 200 mM NaCl / 0.5 mM EDTA / 1 mM dithiothreitol / 
0.2 mM phenylmethanesulphonylfluoride / 0.2 mM benzamidine. The precipitant 
reagents were from a commercial crystal screening kit (Wizard I，Emerald 
BioSystems). Two PDMS microwell patches that contained the protein solution and 
the precipitant reagents were fabricated and then bound. The microwell patches were 
placed in paraffin oil for incubation. After incubation for 24 hours, the bound 
microwell patches were peeled apart while they remained in paraffin oil. 1 |iL of 
glycol as the cryoprotectant was pipetted into the microwells which contained 
crystals. Then the crystals were picked up with a cryoloop (Hampton Research) and 
flash-frozen in liquid nitrogen. The X-ray diffraction data was collected at 100 K 
using a Rigaku MicroMax-007 X-ray generator, and recorded by the R-AXIS IV++ 
IP detector. 
3.3 Results and discussions 
3.3.1 Sparse matrix screening strategy in microwell arrays 
The crystal screening kit (Crystal Screen, Hampton research) is designed to 
provide an effective and rapid screening method for the crystallization of proteins by 
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using the sparse matrix screening strategy. The screening kit contains 50 unique 
conditions with combinations of salts, precipitants, and buffers. Results from an 
initial screen can produce crystals or solubility information, which allows 
optimization or development of rational strategies for subsequent screens. 
A sparse matrix screening using the microwell-based platform was conducted by 
the binding of the two arrays of microwells containing protein solutions and 50 
conditions. Therefore, we have to solve the following issues: (a) the loading of 
multiple reagents with different compositions, surface properties and viscosities; (b) 
the mixing protein solution and precipitants from two separated microwell arrays; (c) 
the incubation of the mixed solutions in the paired microwell array. 
(a) The loading of crystallization reagents into microwells 
To solve the first issue, we employed the current nanoliter liquid dispensing 
method (described in chapter 2) to fill the microwell arrays with protein solution 
and precipitants. 
(b) The mixing of reagents from two open microwell arrays 
Open microwell arrays have been widely employed to perform fluid phase 
reaction/screening. To add reactants to the nanoliter well quantitatively and 
specifically was a challenge, usually with noncontact dispensing technology, such as 
inkjet printing54’ 76 and electrospray dispensing.?? However, these methods suffered 
from the issues on preventing the evaporation of the solvent and the handling of 
difficult liquids with high surface tension and viscosity. Moerman et al developed a 
simple "coverslip" method to introduce sample into nanoliter well pre-filled with 
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substrates.78 This "coverslip" method prevented the evaporation of solutions in 
nanoliter well up to hours allowing monitoring the enzyme-based reaction. However, 
this method was limited by some liquids which wet the surface of the coverslip and 
the microwells and the operation was not feasible. 
a) b) decreasing [Fe(N03)J > 
P f o W e T p a t c K l l t p . - ~ “ � 、 漆 v - J 
闘 p T > i a 
microwell patch g , ‘ ？、、； 
CO • • • •、罄‘、•疾和 
binding ^ ^ ^ , 
Mmmm^nm o 
9 T n I B ^ B � 眷 � i> ： # €) c 
H H f e l ^ ？、’ • ， ， 
mixing in > , | • €> t» 、)， t>、 r €> € 
microchambers 
Figure 3.3 (a) A schematic illustration of the process of the mixing of reagents from two arrays of 
microwells. Different colors represent different reagents, (b) A micrograph of a 6 x 6 array of bound 
patches of microwells containing Fe(SCN)x^''' solutions with a concentration gradient. 
Herein, with the array of droplets in the open microwells, we were able to carry 
out multiplex reaction by binding two arrays of microwells containing the reactants 
to form an array of microchambers (Figure 3.3a). In our experiments, the two 
microwell patches were taken out of the silicone oil bath first, with the surfaces of 
the patches still covered by a thin layer of oil. Aligning the two microwell patches 
during the binding process was crucial for the success of the reaction. With 
microwells of 400 \xm in diameter, we were able to align the two microwell patches 
by eyes, and a stereoscope provided better accuracy. We envision that the addition of 
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alignment posts and holes would facilitate the rapid and precise assembly of the two 
micro well patches During the binding process, the silicone oil between the two 
microwell patches was pushed out gradually. The drainage of the oil film allowed the 
two microwell patches to approach each other slowly and facilitated the alignment 
by eyes. In addition, the oil film prevented the trapping of air bubbles between the 
two patches. Confined in the microwells and surrounded by silicone oil, the droplets 
had a convex-shaped surface, which protruded slightly above the patch surface and 
facilitated the coalescence of the droplets once the two patches were brought into 
contact (Figure 3.3a). Figure 3.3b shows the 6 x 6 array of microchambers 
contained the mixture of Fe(N03)3 and KSCN solutions. The arrays of 
microchambers were from two prefabricated microwell patches, one containing 
droplets with decreasing Fe(N03)3 concentration ([Fe(N03)3]) from left to right, the 
other containing droplets with decreasing KSCN concentration ([KSCN]) from top 
to bottom. Even for large arrays of microwells, the success rate of mixing was 100 %, 
as demonstrated in the 156-trial screening experiment, 
(c) The incubation of crystallizing reagents 
PDMS elastomer is optically transparent, gas permeable, easy to fabricate and 
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very cheap, and has become a major material in microfluidic devices. ’ However, 
it has its own shortcomings such as partial permeability to water or many organic 
molecules. Previous PDMS-based microfluidic crystallization systems suffer from 
the lack of long-term storage of the reagents, such as PDMS pneumatic valves.！々 
Herein, we improved the long-term capability of reagents by two methods: one is 
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submerging the entire PDMS device in a paraffin oil bath, and the other is using 
microwells fabricated of water impermeable materials such as glass. 
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Figure 3.4 Polarized light micrographs of the protein crystals grown in the microwells with the 
optimal precipitant. Scale bar: 200 fim. a) Chicken egg-white lysozyme; precipitant: 0.1 M sodium 
acetate trihydrate buffer, pH 4.6 / 2.0 M sodium formate, b) Horseradish peroxidase; precipitant: 0.2 
M CaCb / 28% (v/v) PEG 400 / 0.1 M (4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid) (HEPES) 
buffer, pH 7.5. c) Xylanase; precipitant: 0.2 M CaCb / 28% (v/v) PEG 400 / 0.1 M HEPES buffer, pH 
7.5. d) Thaumatin; precipitant: 0.8 M potassium sodium tartrate tetrahydrate / 0.1 M HEPES buffer, 
pH7.5. 
The use of paraffin oil bath provides up to three days of incubation duration of 
the crystallization reagents in the microwells. The oil plays an important role in 
macromolecular crystallization.^^'^^ Paraffin oil has been widely used in traditional 
microbatch approach to prevent the evaporation of water?^' Because of the 
extremely small volume of the microwell, the evaporation of the solvent in the 
droplets will be very fast when the PDMS device is directly exposed to air. The 
incubation of PDMS in paraffin oil minimized the evaporation of water through the 
PDMS surface. Figure 3.4 shows the crystals of several testing proteins grown in the 
PDMS microwells, where the incubation time ranging from hours to a few days. As 
shown in the figure, the crystals had clear edges and stopped growing after they 
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entered the cessation stage, indicating the good preservation of the crystallizing 
reagents during the crystal growth process. In addition, the semipermeability of 
PDMS to water can be potentially applied to control the evaporation of water by 
adding extra reservoirs.'^ The PDMS microwell system described here allowed slow 
evaporation of water, which is similar to the modified microbatch by adding different 
types of oil to regulate the evaporation of a drop under the oil.^ ^ 
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Figure 3.5 Series of polarized light micrographs of thaumatin crystals grown in glass microwell, 
where the incubation time was from 1 to 70 days. Scale bar: 200 fim. 
Longer incubation time was achieved by employing glass microwells. By using 
the liquid dispensing method, we can fill arrays of glass microwells through the 
PDMS microchannel patch. Here the channel patch was temporally used and would 
be removed after the filling process. Eventually, we established a PDMS-free 
microfluidic system to incubate the crystallizing reagents with water-impermeable 
substrates such as glass. Figure 3.5 shows a series of pictures of the thaumatin 
crystals in the glass microwells. As shown in the figure, the crystals stopped growing 
after 5 days of incubation, indicating they entered a cessation stage of crystal growth. 
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No obvious loss of the water was observed in more than two month. Furthermore, 
the shapes and edges of the crystals were very clear and stable, implying the 
crystallizing reagents were well protected against the change of the external 
environment such as humidity. 
3.3.2 The results of the sparse matrix screening 
We set up a sparse matrix screening of four testing proteins. For each protein, we 
set up 150 screening trials. Each trial resulted from binding two microwells, which 
contained one droplet of the protein solution and one droplet of a precipitant reagent, 
respectively. The volume of each droplet was � 2 0 nL. Only 5 |aL protein solution or 
less was loaded in the Teflon tubing in the beginning of the experiment for the 150 
screening trials. 
Table 3.1 The screening results of the crystallization conditions of the four known proteins with the 
sparse-matrix screening in microwell array. (Crystal Screening kit: Crystal Screen, Hampton research) 
Protein Conditions 
Lysozyme 2, 6，9，20，27，29，34，25，36，41，42 
Xylanase 1,6, 14, 17,21,24, 45 
Thaumatin 29 
Horseradish peroxidase 1, 6，14, 24, 46 
Notes: The formulations of the precipitants are showed in Appendix I 
We further illustrated the application of the screening method by producing 
diffraction-quality crystals of an unknown protein HP0753. HP0753 is an important 
protein in flagellar biosynthesis. Although there has been some success in expression 
and purification of this protein, no crystal structure has been published. The protein 
crystals grew up to 200 |im after 24-hour incubation using the optimal precipitant 
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(Figure 3.6a). 
Results of the sparse matrix screening in microwell arrays of proteins are shown 
in Table 3.1 and Table 3.2. Table 3.1 illustrates that 100% of the successful rates of 
the crystallization of four testing proteins which have been previously crystallized 
and similar crystallization conditions o f these proteins have been reported b e f o r e . 
For the unknown protein, for the first time, we got two conditions using our 
microwell array (Table 3.2). Three parallel trials of each condition were performed 
on one microchip and the results were consistent. 
Table 3.2 The screening results of the crystallization conditions of protein HP0753 using the method 
in the main text (Screening kit: Wizard I, Emerald BioSystems). 
Protein Conditions 
HP0753 1,28 
Notes: The formulations of the precipitants are showed in Appendix II 
3.3.3 Crystal extraction and X-ray diffraction 
The quality of the protein crystal could be evaluated by either 
cryocrystallography or in situ X-ray diffraction if the microwell patch was made of 
PDMS or glass. 16’ 49’ 82 jj^  the present study, the reversible binding of the two 
microwell patches allowed harvesting the protein crystals from the microwells. We 
were able to peel apart the two microwell patches without disturbing the crystals in 
the microwells (Figure 3.6b), and then we slowly introduced the cryoprotectant into 
the microwells. The crystals were then mounted and subjected to X-ray diffraction 
studies. Diffraction pattern with a resolution of 3.1 A was obtained (Figure 3.6c). 
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Figure 3.6 Polarized light micrographs of the crystals of the novel protein HP0753 in the bound 
microwells (a) and in the disassembled microwell (b), respectively. The precipitant was 20% (v/v) 
PEG 3000 / 0.2 M NaCI / 0.1 M HEPES buffer, pH 7.5. Scale bar: 100 nm. c) X-ray diffraction 
pattern with a resolution of 3.1 A from a crystal of protein HP0753. 
3.4 Conclusion 
In this chapter, I present the current microwell-based microfluidic platform for 
performing the screening of protein crystallization conditions at nanoliter scale. To 
demonstrate the application, 156-microwell array was designed and fabricated. With 
the liquid dispensing method described in the previous chapter, protein solution and 
precipitants were dispensed into two separated microwell arrays. A sparse matrix 
screening was conducted by the binding of such two arrays of reagents. Thus, the 
right crystallization conditions of 4 known proteins and 1 unknown protein were 
obtained after incubation for a certain time. The situation of the lack of long-term 
capability of reagents in PDMS microwell was improved by submerging the entire 
device into a paraffin oil bath. To achieve long term incubation of reagents in the 
paired microwells, water-impermeable glass microwells were employed. In addition, 
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due to the nature of reversible binding between two arrays, crystals were harvested 
by splitting the paired microwell array. X-ray diffraction data of the crystals of the 




Chapter 4. Conclusion 
4.1 Summary 
In this thesis, I describe the microwell-based microfluidic platform and its 
application in sparse matrix screening of conditions of protein crystallization. 
A nanoliter liquid dispensing method was introduced to deliver reagents into the 
microwell array. This liquid system consisted of two components: one removable 
PDMS channel patch and one microwell array patch, which were reversibly bound 
together. An internal vacuum pumping source was generated and pre-stored at the 
degassed PDMS patches, which was subsequently used to aspirate liquids into 
microwells. By removing the channel patch, arrays of reagent droplets were 
fabricated on a two dimensional flat surface and the evaporation of the liquids 
significantly slowed down under the protection of paraffin oil. This liquid dispensing 
method was successfully tested with a wide range of liquids with different 
wettabilities and viscosities. 
With the liquid dispensing method, two arrays of protein and various precipitant 
droplets were fabricated in order to conduct a sparse-matrix screening using the 
conventional crystal screening kit. Protein solution and various precipitants were 
mixed in the paired microwell by the binding of two arrays of the protein and the 
precipitant droplets. 156-trials of screening of the protein crystallization conditions 
of four known proteins and one unknown protein were successfully performed. 
Diffraction-quality crystals of the unknown protein were harvested from the 
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disassemble microwell and subjected to X-ray diffraction study. We improved the 
capability of the storage of reagents in the PDMS microwell up to three days by 
submerging the entire device into a paraffin oil bath. Further more, by employing 
glass microwell, we incubated the crystallizing reagents of thaumatin for more than 
two month without any obvious loss of water or noticeable change of the crystals. 
4.2 Discussions and future directions 
There are several advantages and applications of the current microwell-based 
microfluidic systems. 
(1) The use of degassed PDMS as internal pumping source is simple and fast for 
the end users. The end users only need to degas the PDMS device and a significant 
pumping source will be obtained without the aid of any expensive pressure controller 
or syringe pump. Alternatively, the degassed PDMS patch can be placed in an air 
tight package for storage or transportation, which shows the potential for 
commercialization. 
(2) The use of the removable PDMS filling channel patch is a potentially 
powerful tool for high-throughput technology. It allows large scale of integration of 
the microchannels on patterned substrates. Due to the negative pressure generated by 
the internal vacuum source, leakage- and bubble-free fluids in the microchannels can 
be obtained. Furthermore, the dimension of the filling channel can be very small 
compared to target microchamber, which significantly decreases the waste of 
reagents and increases the efficiency of the liquid transportation. More importantly, 
the temporal use of PDMS channel patch allows creating a PDMS-free microfluidic 
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device after the liquid dispensing, which well addresses the issue on the lack of 
long-term capability of reagent storage in previous PDMS-based microfluidic 
systems. 
(3) The reagent droplets in the open microwell array allow performing nanoliter 
scale bioassays and reactions in fluid phase. The method can be scaled up, and 
hundreds to thousands of microwells can be accommodated on one patch, allowing 
high-throughput screening. On the other hand, the strategy of mixing reactants by 
binding two arrays of reagents offers a platform for multiplex reaction. Furthermore, 
the reversible binding of the microwells facilitates harvesting the product from the 
microwells for further analysis. In addition, the microwell patches can be easily 
accommodated in commercial instrumentation, such as plate readers and robotic 
systems. 
Although this microwell-based platform for protein crystallization has many 
advantages and potential other applications, it still has several issues need to be 
addressed: (i) the density of the microwell. Currently, the largest scale of microwell 
array contains 156 identical microwells on a surface with a density of 25 well/cm ； 
(ii) The volume of the microwell for protein crystallization is 20 nL at present, which 
can be decreased to 10 nL or less; (iii) For protein crystallization, we only perform 
the microbatch method in our microfluidic systems. We plan to extend the 
microfluidic system to other crystallization approaches such as vapor diffusion and 
free interface diffusion. 
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Overall, the microwell platform and the associated screening methods offer a 
simple, inexpensive and reliable way to store and use multiple nanoliter-volume 
distinct reagents in a microwell array format and should be ideally suitable for 
individual laboratories for various applications such as enzyme assay, protein 
crystallization, cell analysis, and combinatorial chemistry. 
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Appendix Information 
Appendix 1 Crystal Screen™ formulation (Hampton Research) 
No. ^ Buffer Precipitant 
0.02 M Calcium chloride 0.1 M Sodium acetate trihydratc 
1 30% v/v (+/-)-2-Melhyl-2,4-pentanecliol 
dihydrate pH 4.6 
0.4 M Potassium sodium tartrate 
2 None None 
tetrahydrate 
3 None None 0.4 M Ammonium phosphate monobasic 
4 None 0.1 M Tris hydrochloride pH 8.5 2.0 M Ammonium sulfate 
0.2 M Sodium citrate Iribasic 
5 0.1 M HEPES sodium pM 7.5 30% v/v (+A)-2-Methyl-2,4-pentanediol 
dihydrate 
0.2 M Magnesium chloride 
6 0.1 M Tris hydrochloride pH 8.5 30% w/v Polyethylene glycol 4,000 
hexahydrate 
0.1 M Sodium cacodylale 
7 N o n e 1.4 M Sodium acetate trihydrate 
trihydrate pH 6.5 
0.2 M Sodium citrate tribasic 0.1 M Sodium cacodylale 
8 30% v/v 2-Propanol 
dihydrate trihydrate pH 6.5 
0.1 M Sodium citrate tribasic 
9 0.2 M Ammonium acetate 30% w/v Polyethylene glycol 4,000 
dihydrate pH 5.6 
0.1 M Sodium acetate trihydrate 
10 0.2 M Ammonium acetate 30% w/v Polyethylene glycol 4,000 
p H 4 . 6 
0.1 M Sodium citrate tribasic 
11 None 1.0 M Ammonium phosphate monobasic 
dihydrate pH 5.6 
0.2 M Magnesium chloride 
12 0.1 M HEPES sodium pH 7.5 30% v/v 2-Propanol 
hexahydrate 
0.2 M Sodium citrate tribasic 
1 3 0.1 M Tris hydrochloride pH 8.5 30% v/v Polyethylene glycol 400 
dihydrate 
0.2 M Calcium chloride 
14 0.1 M HEPES sodium pH 7.5 28% v/v Polyethylene glycol 400 
dihydrate 
0.1 M Sodium cacodylate 
15 0.2 M Ammonium sulfate 30% w/v Polyethylene glycol 8,000 
trihydrate pH 6.5 
16 None 0.1 M HEPES sodium pH 7.5 1.5 M Lithium sulfate monohydrate 
0.2 M Lithium sulfate 
17 0.1 M Tris hydrochloride pH 8.5 30% w/v Polyethylene glycol 4,000 
monohydrate 
0.2 M Magnesium acetate 0.1 M Sodium cacodylate 
18 20% w/v Polyethylene glycol 8,000 
lelrahydrale trihydrate pH 6.5 
19 0.2 M Ammonium acetate 0.1 M Tris hydrochloride pH 8.5 30% v/v 2-Propanol 
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0.1 M Sodium acetate trihydrale 
20 0.2 M Ammonium sulfate 25% w/v Polyethylene glycol 4,000 
pH 4.6 
0.2 M Magnesium acetate 0.1 M Sodium cacodylate 
21 30% v/v (+/-)-2-Methyl-2,4-pentanediol 
tetraliydrate trihydrate pH 6.5 
0.2 M Sodium acetate 
22 0.1 M Tris hydrochloride pH 8.5 30% w/v Polyethylene glycol 4,000 
trihydrate 
0.2 M Magnesium chloride 
23 0.1 M HEPES sodium pH 7.5 30% v/v Polyethylene glycol 400 
hexahydrate 
0.2 M Calcium chloride 0.1 M Sodium acetate trihydrale 
24 20% v/v 2-Propanol 
dihydrate pH 4.6 
25 None 0.1 M Imidazole pH 6.5 1.0 M Sodium acetate trihydrate 
0.1 M Sodium citrate tribasic 
26 0.2 M Ammonium acetate 30% v/v (+/-)-2-Methyl-2’4-pentanediol 
dihydrate pH 5.6 
0.2 M Sodium citrate tribasic 
27 0.1 M HEPES sodium pH 7.5 20% v/v 2-Propanol 
dihydrate 
0.2 M Sodium acetate 0.1 M Sodium cacodylate 
28 30% w/v Polyethylene glycol 8,000 
trihydrate trihydrate pH 6.5 
0.8 M Potassium sodium tartrate 
29 None 0.1 M HEPES sodium pH 7.5 
tetraliydrate 
30 0.2 M Ammonium sulfate None 30% w/v Polyethylene glycol 8,000 
31 0.2 M Ammonium sulfate None 30% w/v Polyethylene glycol 4,000 
32 N o n e None 2.0 M Ammonium sulfate 
33 None None 4.0 M Sodium Ibrmale 
0.1 M Sodium acetate trihydrate 
34 N o n e 2.0 M Sodium formate 
pH 4.6 
0.8 M Sodium phosphate monobasic 
35 None 0.1 M HEPES sodium pH 7.5 monohydrate 
0.8 M Potassium phosphate monobasic 
36 N o n e 0.1 M Tris hydrochloride pH 8.5 8% w/v Polyethylene glycol 8,000 
0.1 M Sodium acetate trihydrate 
37 None 8% w/v Polyethylene glycol 4,000 
pH 4.6 
38 N o n e 0.1 M HEPES sodium pH 7.5 1.4 M Sodium citrate tribasic dihydrate 
2% v/v Polyethylene glycol 400 
39 N o n e 0.1 M HEPES sodium pH 7.5 
2.0 M Ammonium sulfate 
0.1 M Sodium citrate tribasic 20% v/v 2-Propanol 
40 N o n e 
dihydrate pH 5.6 20% w/v Polyethylene glycol 4,000 
10% v/v 2-Propanol 
41 N o n e 0.1 M HEPES sodium pH 7.5 
20% w/v Polyethylene glycol 4,000 
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0.05 M Potassium phosphate 
42 None 20% w/v Polyethylene glycol 8.000 
monobasic 
43 None None 30% w/v Polyethylene glycol 1,500 
44 None None 0,2 M Magnesium formate dihydrate 
0.1 M Sodium cacodylate 
45 0.2 M Zinc acetate dihydrate 18% w/v Polyethylene glycol 8,000 
trihydrate pH 6.5 
0.2 M Calcium acetate 0.1 M Sodium cacodylate 
46 18% w/v Polyethylene glycol 8,000 
hydrate trihydrate pH 6.5 
0.1 M Sodium acetate trihydrate 
47 None 2.0 M Ammonium sulfate 
p H 4 . 6 
48 None 0.1 M Tris hydrochloride pH 8.5 2.0 M Ammonium phosphate monobasic 
1.0 M Lithium sulfate 
49 None 2% w/v Polyethylene glycol 8,000 
monohydrate 
0.5 M Lithium sulfate 
50 None 15% w/v Polyethylene glycol 8,000 
monohydrate 
Appendix 2 Wizard I sparse matrix crystallization screen formulation 
No. I Crystallant Buffer (0.1 M) Salt (0.2 M) 
1 20% (w/v) PEG-8000 CHES pH 9.5 none 
2 10% (v/v) 2-propanol HEPES pH 7.5 NaCl 
3 15% (v/v) ethanol CHES pH 9.5 none 
4 35% (v/v) 2-methyl-2,4-pentanediol imidazole pH 8.0 MgC12 
5 30% (v/v) PEG-400 CAPS pH 10.5 none 
6 20% (w/v) PEG-3000 citrate pH 5.5 none 
7 10% (w/v) PEG-8000 MES pH 6.0 Z n ( 0 A c ) 2 
8 2.0 M ( N H 4 ) 2 S 0 4 citrate pH 5.5 none 
9 1 . 0 M ( N H 4 ) 2 H P 0 4 acetate pH 4.5 none 
10 20% (w/v) PEG-2000 MME Tris pH 7.0 none 
11 20% (v/v) 1,4-butanediol MES pH 6.0 L i 2 S 0 4 
12 20% (w/v) PEG-1000 imidazole pH 8.0 Ca(0Ac)2 
13 1 .26 M ( N H 4 ) 2 S 0 4 cacodylate pH 6.5 none 
14 1.0 M sodium citrate cacodylate pH 6.5 none 
1 5 10% (w/v) PEG-3000 imidazole pH 8.0 L i 2 S 0 4 
16 2.5 M NaCl Na/K phosphate pH 6.2 none 
17 30% (w/v) PEG-8000 acetate pH 4.5 L i 2 S 0 4 
18 1.0 M K/Na tartrate imidazole pH 8.0 NaCl 
19 20% (w/v) PEG-1000 Tris pH 7.0 none 
20 0.4 M N a H 2 P 0 4 / 1 . 6 M K 2 H P 0 4 imidazole pH 8.0 NaCl 
21 20% (w/v) PEG-8000 HEPES pH 7.5 none 
22 10% (v/v) 2-propanol Tris pH 8.5 none 
23 15% (v/v) ethanol imidazole pH 8.0 MgC12 
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24 35% (v/v) 2-methyl-2,4-pentanediol Tris pH 7.0 NaCl 
25 30% (v/v) PEG-400 Tris pH 8.5 MgC12 
26 10% (w/v) PEG-3000 CHES pH 9.5 none 
27 1.2 M NaH2P04 /0 .8 M K 2 H P 0 4 CAPS pH 10.5 L i 2 S 0 4 
28 20% (w/v) PEG-3000 HEPES pH 7.5 NaCl 
29 10% (w/v) PEG-8000 CHES pH 9.5 NaCl 
30 1 . 2 6 M ( N H 4 ) 2 S 0 4 acetate pH 4.5 NaCl 
31 20% (w/v) PEG-8000 phosphate-citrate pH 4.2 NaCl 
32 10% (w/v) PEG-3000 Na/K phosphate pH 6.2 none 
33 2.0 M ( N H 4 ) 2 S 0 4 CAPS pH 10.5 L i 2 S 0 4 
34 1.0 M ( N H 4 ) 2 H P 0 4 imidazole pH 8.0 none 
35 20% (v/v) 1,4-butanediol acetate pH 4.5 none 
36 1.0 M sodium citrate imidazole pH 8.0 none 
37 2.5 M NaCl imidazole pH 8.0 none 
38 1.0 M K / N a tartrate CHES pH 9.5 L i 2 S 0 4 
39 20% (w/v) PEG-1000 phosphate-citrate pH 4.2 L i 2 S 0 4 
40 10% (v/v) 2-propanol MES p H 6 . 0 Ca(0Ac)2 
41 30% (w/v) PEG-3000 CHES pH 9,5 none 
42 15% (v/v) ethanol Tris pH 7.0 none 
43 35% (v/v) 2-methyl-2,4-pentanediol Na/K phosphate pH 6.2 none 
44 30% (v/v) PEG-400 acetate pH 4.5 Ca(0Ac)2 
45 20% (w/v) PEG-3000 acetate pH 4.5 none 
46 10% (w/v) PEG-8000 imidazole pH 8.0 Ca(0Ac)2 
47 1 . 2 6 M ( N H 4 ) 2 S 0 4 Tris pH 8.5 L i 2 S 0 4 
48 20% (w/v) PEG-1000 acetate pH 4.5 Zn(0Ac)2 
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